Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
23.00    -1.00 (-4.17%)
Bid:
22.00
Ask:
24.00
Spread: 2.00 (9.091%)
Market Cap: £24.84m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Derivative Claim - Update

18 Jun 2015 08:50

RNS Number : 5360Q
Elektron Technology PLC
18 June 2015
 



Elektron Technology plc 

("Elektron" or the "Company")

 

Derivative Claim - Update

 

In its 2015 Annual Report, on page 18, the Company provided an update in relation to the derivative litigation brought by a shareholder, Mr Bridge, who holds at the date of this announcement 1.83% of the Company's ordinary shares.

On 16 and 17 June 2015 Mr Bridge's application for permission to continue the intended claim against certain current directors, Keith Daley and John Wilson, and certain former directors, Noah Franklin and Simon Acland, (together "the Directors") was considered by the High Court in the Liverpool District Registry.

 

Mr Bridge represented himself at the hearing and both the Company and the Directors were represented by counsel instructed by their respective solicitors.

Permission has been refused by His Honour Judge Hodge QC with the effect that, subject to rights of appeal, the Derivative Claim will not continue.

In his judgment refusing permission, and addressing the Company's case, Judge Hodge QC was entirely satisfied that this was a clear case where the Court should refuse permission. The nature and strength of the claim, in light of the evidence of the Directors and the difficulty in establishing loss to the Company, were such that no reasonable director would support continuation of the litigation.His Lordship was satisfied that the Court should not compel the Company to continue the litigation when disinterested shareholders were not in support, and neither was the independent board.The Judge, having noted that a failure to properly and impartially consider the Company's evidence was a feature that had permeated all of Mr Bridge's submissions, accepted the Company's submission that the way Mr Bridge had conducted the litigation meant that it would not be appropriate to allow him to conduct litigation on the Company's behalf, or to require the Company to lend its name to the action.Mr Bridge has been ordered to pay all the costs of the Company and the Directors. He must make payments on account in the sums of £40,000 (in respect of the Company's costs) and £50,000 (in respect of the costs of the Directors) by close of business on 15 July 2015. Further, costs incurred after the wasted hearing on 1 October 2014 have been awarded on the indemnity basis as, by that time and with the benefit of legal representation, Mr Bridge should have seen the action as doomed for failure. His decision to continue it took the case "outside the commercial norm".

Mr Bridge did not apply for permission to appeal at the hearing, but he has 21 days from 17 June 2015 to do so. Any application for permission would need to be made to the Court of Appeal, setting out his grounds.Further updates will be provided in due course as appropriate.

 

 

For further information:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

Andy Weatherstone - Chief Financial Officer

Martin Reeves - Company Secretary

finnCap

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

 

 

Notes to Editors

 

Elektron conceives, designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas:

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Internet of Things, cloud computing and mobile devices: enabling automation and management of a new wave of business processes: Checkit

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition, Elektron owns a portfolio of well-established products and brands which provide customer access and feedback.

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSDRAITLIE
Date   Source Headline
20th Apr 20187:00 amRNSNotice of Results
10th Apr 20187:00 amRNSCheckit passes £1 million annual recurring revenue
29th Mar 20187:00 amRNSBulgin announces agreement with Arrow Electronics
6th Mar 20187:00 amRNSFSA successfully completes trials with Checkit
27th Feb 20187:00 amRNSHolding(s) in Company
16th Feb 20187:00 amRNSDisposal of Queensgate Nano
8th Feb 20187:00 amRNSTrading Statement
26th Jan 20183:37 pmRNSHolding(s) in Company
25th Jan 20185:58 pmRNSHolding(s) in Company
25th Jan 20187:00 amRNSAcquisition of IP in EET business
19th Jan 20183:45 pmRNSHolding(s) in Company
2nd Jan 20187:00 amRNSChange of Nominated Adviser and Broker
12th Dec 20177:00 amRNSGrant of Options
6th Dec 20174:02 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSTrading Statement
23rd Oct 20174:16 pmRNSDirector/PDMR Shareholding
20th Oct 20177:00 amRNSDisposal of Sheen Instruments
16th Oct 201712:25 pmRNSHolding(s) in Company
27th Sep 20174:20 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
19th Sep 20177:00 amRNSContract Win
10th Aug 20177:00 amRNSTrading Update and Notification of Interim Results
31st Jul 20177:00 amRNSDisposal
13th Jul 201710:01 amRNSHolding(s) in Company
6th Jul 20173:00 pmRNSResult of AGM
6th Jul 20177:00 amRNSAGM Statement
16th Jun 201710:40 amRNSHolding(s) in Company
13th Jun 20177:57 amRNSHolding(s) in Company
6th Jun 201711:26 amRNSAnnual Report and Notice of AGM
18th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSNotice of Results & AGM
27th Mar 20177:00 amRNSDisposal
8th Feb 20177:00 amRNSTrading Update
19th Jan 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20164:54 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20169:00 amRNSReview of Operations
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.